Pharmacology of benzydamine

Inflammopharmacology

Volumn 6, Issue 2, 1998, Pages 95-107

  Quane, P A ^a   Graham, G G ^a   Ziegler, J B ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Benzydamine; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; BENZYDAMINE; CYTOKINE; HISTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; CELL GRANULE; CONTROLLED STUDY; DRUG BLOOD LEVEL; GEL; GUINEA PIG; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MACROPHAGE; MEMBRANE STABILIZATION; MOUSE; MOUTHWASH; NEUTROPHIL; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHARMACOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; RESPIRATORY BURST; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0031859436     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-998-0026-0     Document Type: Review

References (57)

1. 1. B Silvestrini P Scorza Barcellona A Garau B Catanese 1967 Toxicology of benzydamine Toxicol Appl Pharmacol 10 148 59 6031923 10.1016/0041-008X(67)90136-6 1:CAS:528:DyaF2sXosVGqug%3D%3D Silvestrini B, Scorza Barcellona P, Garau A, Catanese B. Toxicology of benzydamine. Toxicol Appl Pharmacol. 1967;10:148–59.
2. 2. C Hansch PG Sammes JB Taylor 1990 CJ Drayton Comprehensive Medicinal Chemistry, Volume 6 Pergamon Press Oxford 309 309 Hansch C, Sammes PG, Taylor JB. In: Drayton CJ, ed. Comprehensive Medicinal Chemistry, Volume 6. Oxford: Pergamon Press; 1990:309.
3. 3. JM Jez JM Vanderkooi AM Laties 1996 Spectroscopic characterization of benzdazac and benzydamine: possible photochemical modes of action Biochem Biophys Res Commun 221 266 70 8619844 10.1006/bbrc.1996.0584 1:CAS:528:DyaK28XisVaht7w%3D Jez JM, Vanderkooi JM, Laties AM. Spectroscopic characterization of benzdazac and benzydamine: possible photochemical modes of action. Biochem Biophys Res Commun. 1996;221:266–70.
4. 4. GA Baldock RR Brodie LF Chasseaud T Taylor LM Walmsley B Catanese 1991 Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects Biopharm Drug Dispos 12 481 92 1932611 10.1002/bdd.2510120702 1:CAS:528:DyaK3MXmt1aksbs%3D Baldock GA, Brodie RR, Chasseaud LF, Taylor T, Walmsley LM, Catanese B. Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharm Drug Dispos. 1991;12:481–92.
5. 5. RD Schoenwald T Kumakura B Catanese 1987 Pharmacokinetics of benzydamine Int J Tiss React 9 9 7 Schoenwald RD, Kumakura T, Catanese B. Pharmacokinetics of benzydamine. Int J Tiss React. 1987;9:9–7.
6. 6. AH Beckett EJ Triggs 1967 Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes J Pharm Pharmacol 19 31S 41S 4383854 Beckett AH, Triggs EJ. Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes. J Pharm Pharmacol. 1967;19:31S-41S.
7. 7. MH Bickel HJ Weder 1969 Buccal absorption and other properties of pharmacokinetic importance of imipramine and its metabolites J Pharm Pharmacol 21 160 8 4388211 1:CAS:528:DyaF1MXpsFSqsw%3D%3D Bickel MH, Weder HJ. Buccal absorption and other properties of pharmacokinetic importance of imipramine and its metabolites. J Pharm Pharmacol. 1969;21:160–8.
8. 8. LF Chasseaud B Catanese 1985 Pharmacokinetics of benzydamine Int J Tiss React 7 195 204 1:CAS:528:DyaL2MXlvVyqsbw%3D Chasseaud LF, Catanese B. Pharmacokinetics of benzydamine. Int J Tiss React. 1985;7:195–204.
9. 9. K Andersson H Larsson 1974 Percutaneous absorption of benzydamine in guinea pig and man Arzneimittelforschung 24 1686 8 4479782 1:CAS:528:DyaE2MXhs1ClsbY%3D Andersson K, Larsson H. Percutaneous absorption of benzydamine in guinea pig and man. Arzneimittelforschung. 1974;24:1686–8.
10. 10. R Lisciani P Scorza Barcellona B Silvestrini 1968 Researches on the topical activity of benzydamine Eur J Pharmacol 3 157 62 5666012 10.1016/0014-2999(68)90069-1 1:CAS:528:DyaF1cXktFOrtb8%3D Lisciani R, Scorza Barcellona P, Silvestrini B. Researches on the topical activity of benzydamine. Eur J Pharmacol. 1968;3:157–62.
11. 11. E Giacalone L Valzelli 1966 A method for the determination of 1-benzyl-3[3′-(dimethylamino) propoxy]-1H-indazole (benzydamine) in rat tissues Med Pharmacol Exp 15 102 6 1:CAS:528:DyaF28XltVagtLs%3D Giacalone E, Valzelli L. A method for the determination of 1-benzyl-3[3′-(dimethylamino) propoxy]-1H-indazole (benzydamine) in rat tissues. Med Pharmacol Exp. 1966;15:102–6.
12. 12. S Kataoka K Nishimura T Naito 1979 In vivo metabolism and anti-inflammatory activity of benzydamine hydrochloride in rats treated with carrageenin Chem Pharm Bull (Tokyo) 27 2890 903 1:CAS:528:DyaL3cXht1Wnu70%3D Kataoka S, Nishimura K, Naito T. In vivo metabolism and anti-inflammatory activity of benzydamine hydrochloride in rats treated with carrageenin. Chem Pharm Bull (Tokyo). 1979;27:2890–903.
13. 13. B Catanese R Lisciani D Piccinelli 1969 Erythrocyte membrane stabilization and protein binding of some anti-inflammatory drugs and of deoxycholic acid Biochem Pharmacol 18 1707 10 5806111 10.1016/0006-2952(69)90160-9 1:CAS:528:DyaF1MXks12jtbs%3D Catanese B, Lisciani R, Piccinelli D. Erythrocyte membrane stabilization and protein binding of some anti-inflammatory drugs and of deoxycholic acid. Biochem Pharmacol. 1969;18:1707–10.
14. 14. A Benedetto A Cassone C Amici E Garaci 1979 Enhanced uptake of actinomycin D in cultured mammalian cells by the anti-inflammatory non-steroidal drug benzydamine Biochem Pharmacol 28 2723 8 115474 10.1016/0006-2952(79)90554-9 1:CAS:528:DyaL3cXoslynsQ%3D%3D Benedetto A, Cassone A, Amici C, Garaci E. Enhanced uptake of actinomycin D in cultured mammalian cells by the anti-inflammatory non-steroidal drug benzydamine. Biochem Pharmacol. 1979;28:2723–8.
15. 15. B Catanese A Grasso B Silvestrini 1985 Studies on the absorption and elimination of benzydamine in the mouse, rat, dog and man Arzneimittelforschung 35 634 5 Catanese B, Grasso A, Silvestrini B. Studies on the absorption and elimination of benzydamine in the mouse, rat, dog and man. Arzneimittelforschung. 1985;35:634–5.
16. 16. C Köppel Tenczer 1985 Metabolism of benzydamine Arzneimittelforschung 35 634 5 4039589 Köppel C, Tenczer. Metabolism of benzydamine. Arzneimittelforschung. 1985;35:634–5.
17. 17. NH Fanaki MA El-Nakeeb 1996 Antibacterial activity of benzydamine and antibiotic-benzydamine combinations against multifold resistant clinical isolates Arzneimittelforschung 46 320 3 8901158 1:CAS:528:DyaK28Xis1Sis7s%3D Fanaki NH, El-Nakeeb MA. Antibacterial activity of benzydamine and antibiotic-benzydamine combinations against multifold resistant clinical isolates. Arzneimittelforschung. 1996;46:320–3.
18. 18. NH Fanaki MA el-Nakeeb 1992 Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent J Chemother 4 347 52 1287137 1:CAS:528:DyaK3sXkt1CntLo%3D Fanaki NH, el-Nakeeb MA. Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. J Chemother. 1992;4:347–52.
19. 19. SK White 1988 The pharmacology of benzydamine Res Clin Forums 10 8 23 White SK. The pharmacology of benzydamine. Res Clin Forums. 1988;10:8–23.
20. 20. JR Boissier JM Lwoff F Hertz 1970 Action comparee de six anti-inflammatory non steroidiques Therapie 25 43 60 5436803 1:CAS:528:DyaE3cXktFejsbg%3D Boissier JR, Lwoff JM, Hertz F. Action comparee de six anti-inflammatory non steroidiques. Therapie. 1970;25:43–60.
21. 21. Y Yamatake H Kato K Takagi 1975 Effects of vasoactive agents on the canine forelimb venous perfusion preparation and their modification by anti-inflammatory drugs Jpn J Pharmacol 25 129 39 1:CAS:528:DyaE2MXltVyqtrg%3D Yamatake Y, Kato H, Takagi K. Effects of vasoactive agents on the canine forelimb venous perfusion preparation and their modification by anti-inflammatory drugs. Jpn J Pharmacol. 1975;25:129–39.
22. 22. S Fantato M Gregorio De 1971 Clinical evaluation of topical benzydamine in traumatology Arzneimittelforschung 21 1530 3 4945249 1:STN:280:DyaE387gtVejsQ%3D%3D Fantato S, De Gregorio M. Clinical evaluation of topical benzydamine in traumatology. Arzneimittelforschung. 1971;21:1530–3.
23. 23. DS Chatterjee 1977 A double blind clinical study with benzydamine 3% on soft tissue injuries in an occupational health centre J Int Med Res 5 450 8 338395 1:STN:280:DyaE1c%2FmsFSjsA%3D%3D Chatterjee DS. A double blind clinical study with benzydamine 3% on soft tissue injuries in an occupational health centre. J Int Med Res. 1977;5:450–8.
24. 24. J Froom V Boisseau 1979 Benzydamine oral rinse for sore throat Curr Ther Res 26 856 61 Froom J, Boisseau V. Benzydamine oral rinse for sore throat. Curr Ther Res. 1979;26:856–61.
25. 25. MW Whiteside 1982 A controlled study of benzydamine oral rinse (“Difflam”) in general practice Curr Med Res Opin 8 188 90 7128190 1:STN:280:DyaL3s%2Fis1erug%3D%3D Whiteside MW. A controlled study of benzydamine oral rinse (“Difflam”) in general practice. Curr Med Res Opin. 1982;8:188–90.
26. 26. JB Epstein P Stevenson-Moore 1986 Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy Oral Surg Oral Med Oral Pathol 62 145 8 3528978 10.1016/0030-4220(86)90035-6 1:STN:280:DyaL28zht1ejsg%3D%3D Epstein JB, Stevenson-Moore P. Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Oral Surg Oral Med Oral Pathol. 1986;62:145–8.
27. 27. ST Sonis ST Clairmont PB Lockhart SF Connolly 1985 Benzydamine HCl in the management of chemotherapy-induced mucositis. I. Pilot study J Oral Med 40 67 71 3858465 1:STN:280:DyaL2M3htVansw%3D%3D Sonis ST, Clairmont ST, Lockhart PB, Connolly SF. Benzydamine HCl in the management of chemotherapy-induced mucositis. I. Pilot study. J Oral Med. 1985;40:67–71.
28. 28. A Valijan 1989 Pain relief after tonsillectomy Anaesthesia 44 990 1 2619026 10.1111/j.1365-2044.1989.tb09205.x 1:STN:280:DyaK3c7ksFCrug%3D%3D Valijan A. Pain relief after tonsillectomy. Anaesthesia. 1989;44:990–1.
29. 29. RW Matthews CM Scully BGH Levers 1987 Clinical evaluation of benzydamine, chlorohexidine, and placebo mouthwashes in the management of recurrent aphthous stomatis Oral Surg Oral Med Oral Pathol 63 189 91 3469601 10.1016/0030-4220(87)90310-0 1:STN:280:DyaL2s7ksFKhtg%3D%3D Matthews RW, Scully CM, Levers BGH. Clinical evaluation of benzydamine, chlorohexidine, and placebo mouthwashes in the management of recurrent aphthous stomatis. Oral Surg Oral Med Oral Pathol. 1987;63:189–91.
30. 30. KMacD Hunter 1978 A clinical evaluation of benzydamine hydrochloride Aust Dent J 23 164 6 361026 1:STN:280:DyaE1M%2FktFejtQ%3D%3D Hunter KMacD. A clinical evaluation of benzydamine hydrochloride. Aust Dent J. 1978;23:164–6.
31. 31. R Adame Sosa A Gomez Pedroso 1990 Evaluation of benzydamine in treatment of secondary inflammation following extraction of third molars Pract Odontol 11 29 31 2132273 1:STN:280:DyaK38%2FntlaksQ%3D%3D Adame Sosa R, Gomez Pedroso A. Evaluation of benzydamine in treatment of secondary inflammation following extraction of third molars. Pract Odontol. 1990;11:29–31.
32. 32. L Tomazzoli MR Bonora L Luparini MG Durando V Ciolo L Bonomi 1989 Effects of benzydamine on the rabbit’s eye reaction to surgical, physical and chemical stimuli J Ocul Pharmacol 5 71 80 2715678 1:CAS:528:DyaL1MXktVSksrg%3D 10.1089/jop.1989.5.71 Tomazzoli L, Bonora MR, Luparini L, Durando MG, Ciolo V, Bonomi L. Effects of benzydamine on the rabbit’s eye reaction to surgical, physical and chemical stimuli. J Ocul Pharmacol. 1989;5:71–80.
33. 33. SA Saeed PA Kendall NM Butt HOJ Collier 1979 On the mode of action and biochemical properties of anti-inflammatory drugs Biochem Soc Trans 7 655 7 113266 1:CAS:528:DyaL3cXhsFarsA%3D%3D Saeed SA, Kendall PA, Butt NM, Collier HOJ. On the mode of action and biochemical properties of anti-inflammatory drugs. Biochem Soc Trans. 1979;7:655–7.
34. 34. R Müller-Peddinghaus M Wurl G Lenoir A Houben J Remacle 1987 Einfluss von benzydamin auf bildung ung interacktion von reaktiven sauerstoffspezies und die zyklo-und lipoxigenase Arzneimittelforschung 37 601 5 3040020 Müller-Peddinghaus R, Wurl M, Lenoir G, Houben A, Remacle J. Einfluss von benzydamin auf bildung ung interacktion von reaktiven sauerstoffspezies und die zyklo-und lipoxigenase. Arzneimittelforschung. 1987;37:601–5.
35. 35. G Segre S Hammarström 1985 Aspects of the mechanisms of action of benzydamine Int J Tiss React 7 187 93 1:CAS:528:DyaL2MXlvVyqsb8%3D Segre G, Hammarström S. Aspects of the mechanisms of action of benzydamine. Int J Tiss React. 1985;7:187–93.
36. 36. HP Rang MM Dale JM Ritter 1995 Pharmacology 3rd edn. Churchill Livingstone Edinburgh 230 230 Rang HP, Dale MM, Ritter JM. In: Pharmacology, 3rd edn. Edinburgh: Churchill Livingstone; 1995:230.
37. 37. BM Löffler E Bohn B Hesse H Kunze 1987 The action of benzydamine on phospholipase activation Arzneimittelforschung 37 618 21 3619982 Löffler BM, Bohn E, Hesse B, Kunze H. The action of benzydamine on phospholipase activation. Arzneimittelforschung. 1987;37:618–21.
38. 38. S Moncada P Needleman S Bunting JR Vane 1976 Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition Prostaglandins 12 323 35 968048 10.1016/0090-6980(76)90014-9 1:CAS:528:DyaE28XlsFGnsrg%3D Moncada S, Needleman P, Bunting S, Vane JR. Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition. Prostaglandins. 1976;12:323–35.
39. 39. U Diczfalusy S Hammarström 1977 Inhibitors of thromboxane synthase in human platelets FEBS Lett 82 107 10 10.1016/0014-5793(77)80896-X 1:CAS:528:DyaE1cXit1yl Diczfalusy U, Hammarström S. Inhibitors of thromboxane synthase in human platelets. FEBS Lett. 1977;82:107–10.
40. 40. WCM Jansen 1987 Antithrombotische wirking von benzydamin Arzneimittelforschung 37 626 8 3619983 1:CAS:528:DyaL2sXksFWksbg%3D Jansen WCM. Antithrombotische wirking von benzydamin. Arzneimittelforschung. 1987;37:626–8.
41. 41. RJ Flower HS Cheung DW Cushman 1973 Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonic oxygenase (prostaglandin synthetase) system of bovine seminal vesicle Prostaglandins 4 325 41 4783568 10.1016/0090-6980(73)90020-8 1:CAS:528:DyaE2cXmslKltw%3D%3D Flower RJ, Cheung HS, Cushman DW. Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonic oxygenase (prostaglandin synthetase) system of bovine seminal vesicle. Prostaglandins. 1973;4:325–41.
42. 42. V Dinnendahl HD Peters PS Schönhöfer 1976 Effects of benzydamine on the lipolytic system of fat cells Biochem Pharmacol 25 299 303 178318 10.1016/0006-2952(76)90218-5 1:CAS:528:DyaE28XktFers70%3D Dinnendahl V, Peters HD, Schönhöfer PS. Effects of benzydamine on the lipolytic system of fat cells. Biochem Pharmacol. 1976;25:299–303.
43. 43. M Akamatsu Y Miura 1972 Inhibition of amino sugar formation by several non-steroid anti-inflammatory agents Biochem Pharmacol 21 1991 3 4649346 10.1016/0006-2952(72)90012-3 1:CAS:528:DyaE38XkvFKku7k%3D Akamatsu M, Miura Y. Inhibition of amino sugar formation by several non-steroid anti-inflammatory agents. Biochem Pharmacol. 1972;21:1991–3.
44. 44. M Baggiolini P Mauderli U Näf B Catanese 1985 Effect of benzydamine on exocytosis and respiratory burst in human neutrophils and mononuclear phagocytes Agents Actions 16 346 52 2996321 10.1007/BF01982871 1:CAS:528:DyaL2MXkvFyntrs%3D Baggiolini M, Mauderli P, Näf U, Catanese B. Effect of benzydamine on exocytosis and respiratory burst in human neutrophils and mononuclear phagocytes. Agents Actions. 1985;16:346–52.
45. 45. M Sironi P Pozzi N Polentarutti 1996 Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine Cytokines 8 710 16 10.1006/cyto.1996.0094 1:CAS:528:DyaK28Xmsl2ksbo%3D Sironi M, Pozzi P, Polentarutti N et al. Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Cytokines. 1996;8:710–16.
46. 46. R Müller-Peddinghaus M Wurl 1987 The amplified chemiluminescence test to characterize antirheumatic drugs as oxygen radical scavengers Biochem Pharmacol 36 1125 32 3032204 10.1016/0006-2952(87)90423-0 Müller-Peddinghaus R, Wurl M. The amplified chemiluminescence test to characterize antirheumatic drugs as oxygen radical scavengers. Biochem Pharmacol. 1987;36:1125–32.
47. 47. Y Oyanagui 1976 Inhibition of superoxide anion production in macrophages by anti-inflammatory drugs Biochem Pharmacol 25 1473 80 8043 10.1016/0006-2952(76)90063-0 1:CAS:528:DyaE28XltVekurk%3D Oyanagui Y. Inhibition of superoxide anion production in macrophages by anti-inflammatory drugs. Biochem Pharmacol. 1976;25:1473–80.
48. 48. B Silvestrini A Garau C Pozzatti V Cioli B Catanese 1966 Additional pharmacological studies on benzydamine Arch Int Pharmacodyn Ther 163 61 9 5970856 1:CAS:528:DyaF28XltVantro%3D Silvestrini B, Garau A, Pozzatti C, Cioli V, Catanese B. Additional pharmacological studies on benzydamine. Arch Int Pharmacodyn Ther. 1966;163:61–9.
49. 49. S Simard-Savoie D Forest 1978 Topical anaesthetic activity of benzydamine Curr Ther Res 6 734 5 Simard-Savoie S, Forest D. Topical anaesthetic activity of benzydamine. Curr Ther Res. 1978;6:734–5.
50. 50. V Cioli C Corradino P Scorza Barcellona 1985 Review of pharmacological data on benzydamine Int J Tiss React 8 205 13 Cioli V, Corradino C, Scorza Barcellona P. Review of pharmacological data on benzydamine. Int J Tiss React. 1985;8:205–13.
51. 51. J Buritova D Fletcher P Honore J-M Besson 1996 Effects of local anaesthetics on carrageenan-evoked inflammatory nocioceptive processing in the rat Br J Anaesth 77 645 52 8957983 1:CAS:528:DyaK2sXhvFeltg%3D%3D Buritova J, Fletcher D, Honore P, Besson J-M. Effects of local anaesthetics on carrageenan-evoked inflammatory nocioceptive processing in the rat. Br J Anaesth. 1996;77:645–52.
52. 52. JL Pedersen T Callesen S Moiniche H Kehlet 1996 Analgesic and anti-inflammatory effects of lignocaine-prilocaine (EMLA) cream in human burn injury Br J Anaesth 76 806 10 8679354 1:CAS:528:DyaK28XksFeisb8%3D Pedersen JL, Callesen T, Moiniche S, Kehlet H. Analgesic and anti-inflammatory effects of lignocaine-prilocaine (EMLA) cream in human burn injury. Br J Anaesth. 1996;76:806–10.
53. 53. K Goto M Hisadome H Imamura 1977 Effects of tinoridine on stability of rat liver and kidney lysosomes and liver parenchymal cells Biochem Pharmacol 26 11 18 576205 10.1016/0006-2952(77)90123-X 1:CAS:528:DyaE2sXhs1Ghtr4%3D Goto K, Hisadome M, Imamura H. Effects of tinoridine on stability of rat liver and kidney lysosomes and liver parenchymal cells. Biochem Pharmacol. 1977;26:11–18.
54. 54. K Irita I Fujita S Takeshige S Minakami J Yoshitake 1986 Cinchocaine and amethocaine inhibit activation and activity of superoxide production of human neutrophils Br J Anaesth 58 639 45 3011043 10.1093/bja/58.6.639 1:CAS:528:DyaL28XktlGmtb8%3D Irita K, Fujita I, Takeshige S, Minakami S, Yoshitake J. Cinchocaine and amethocaine inhibit activation and activity of superoxide production of human neutrophils. Br J Anaesth. 1986;58:639–45.
55. 55. R Anderson G Ramafi AJ Theron 1996 Membrane stabilizing anti-oxidative interactions of propranolol and dexpropranolol with neutrophils Biochem Pharmacol 52 341 9 8694859 10.1016/0006-2952(96)00212-2 1:CAS:528:DyaK28Xkt1Krt70%3D Anderson R, Ramafi G, Theron AJ. Membrane stabilizing anti-oxidative interactions of propranolol and dexpropranolol with neutrophils. Biochem Pharmacol. 1996;52:341–9.
56. 56. TM Neal MC Vissers CC Winterbourn 1987 Inhibition of nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine Biochem Pharmacol 36 2511 17 3038127 10.1016/0006-2952(87)90524-7 1:CAS:528:DyaL2sXlt1Kks7w%3D Neal TM, Vissers MC, Winterbourn CC. Inhibition of nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol. 1987;36:2511–17.
57. 57. TM Neal MC Vissers CC Winterbourn 1987 Inhibition of neutrophil-mediated degradation of isolated basement membrane collagen by nonsteroidal antiinflammatory drugs that inhibit degranulation Arthritis Rheum 30 908 13 3632731 10.1002/art.1780300810 1:CAS:528:DyaL2sXls1ynsbc%3D Neal TM, Vissers MC, Winterbourn CC. Inhibition of neutrophil-mediated degradation of isolated basement membrane collagen by nonsteroidal antiinflammatory drugs that inhibit degranulation. Arthritis Rheum. 1987;30:908–13.